We wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e, Monday 11th May 2026, has inter alia considered and approved the standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 16.6 pts less than Nifty Microcap 250 and 17.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Asarfi Hospital Limited reported strong financial performance for FY 2025-26. Standalone revenue grew 42% to Rs 17,320 Lakhs from Rs 12,178 Lakhs, while consolidated revenue reached Rs 17,350 Lakhs. Profit After Tax (PAT) on standalone basis increased 55% to Rs 1,708 Lakhs (vs Rs 1,098 Lakhs), and consolidated PAT rose 57.5% to Rs 1,666 Lakhs (vs Rs 1,058 Lakhs). EPS improved to Rs 8.68 (standalone) and Rs 8.47 (consolidated). Operating cash flow turned positive at Rs 1,909 Lakhs standalone and Rs 1,830 Lakhs consolidated, compared to negative cash flows in the previous year. The auditors issued unmodified opinions on both standalone and consolidated financials. The company operates only in the hospital segment and has one subsidiary - Asarfi Educational Foundation.
The company delivered robust double-digit growth in both revenue and profitability, with cash flow conversion improving significantly. Unmodified auditor opinions indicate clean financials with no material concerns. Shareholders can view these results positively given the strong operational performance and improved cash generation.